Ticker
APVOCompany Name
APTEVO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -23.76M | 0% | $ 0 |
3/31/2025 | $ -23.4M | 0% | $ 0 |
12/31/2024 | $ -23.78M | 0% | $ 0 |
9/30/2024 | $ -23.32M | 0% | $ 0 |
6/30/2024 | $ -24.52M | 0% | $ 0 |
3/31/2024 | $ -26.52M | 0% | $ 0 |
12/31/2023 | $ -16.84M | 0% | $ 0 |
9/30/2023 | $ -15.54M | 0% | $ 0 |
6/30/2023 | $ -16.75M | 0% | $ 0 |
3/31/2023 | $ 19.33M | 0% | $ 0 |
EBITDA / Revenues
(=) EBITDA %
EBITDA % for APTEVO THERAPEUTICS INC is calculated as follows: EBITDA [ $ -16.27M ] / Revenues [ $ 10.97M ]
(=) EBITDA % [ -148.4% ]
Minimum
Mar 31, 2021
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.29K |
---|---|
min | -74.33% |
max | 97.24% |
average | 16.2% |
median | 14.74% |
std | 26.73% |